High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML – YES

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Multiple sclerosis 2017-05, Vol.23 (6), p.765-767
Hauptverfasser:	Yap, Siew Mei, McGuigan, Christopher
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Humans Immunologic Factors - adverse effects Immunotherapy JC Virus - immunology Leukoencephalopathy, Progressive Multifocal - blood Leukoencephalopathy, Progressive Multifocal - diagnostic imaging Leukoencephalopathy, Progressive Multifocal - etiology Magnetic Resonance Imaging Monoclonal antibodies Multiple Sclerosis, Relapsing-Remitting - drug therapy Natalizumab - adverse effects Practice Guidelines as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!